Branched, tripartite-interfering RNAs silence multiple target genes with long guide strands

Nucleic Acid Therapeutics

Volumn 22, Issue 1, 2012, Pages 30-39

  Chang, Chan Il ^a,b   Lee, Tae Yeon ^a   Yoo, Jae Wook ^a   Shin, Duckhyang ^c   Kim, Meehyein ^d   Kim, Soyoun ^e   Lee, Dong Ki ^a  

^a Sungkyunkwan University   (South Korea)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Mogam Biotechnology Research Institute   (South Korea)

^d Korea Research Institute of Chemical Technology   (South Korea)

^e Dongguk University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; DICER; NANOMATERIAL; SMALL INTERFERING RNA;

ARTICLE; DRUG POTENCY; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; MAMMAL CELL; PRIORITY JOURNAL; RNA INTERFERENCE; RNA PROCESSING; RNA STRUCTURE;

BASE SEQUENCE; CELL LINE; GENE SILENCING; HUMANS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING;

EID: 84863115420     PISSN: 21593337     EISSN: None     Source Type: Journal    
DOI: 10.1089/nat.2011.0315     Document Type: Article

References (30)

1. AIGNER, A. (2006). Gene silencing through RNA interference (RNAi) in vivo: strategies based on the direct application of siRNAs. J. Biotechnol. 124, 12-25. (Pubitemid 43816129)
2. BERNSTEIN, E., CAUDY, A.A., HAMMOND, S.M., and HANNON, G.J. (2001). Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409, 363-366. (Pubitemid 32151243)
3. BODEN, D., PUSCH, O., LEE, F., TUCKER, L., and RAMRATNAM, B. (2003). Human immunodeficiency virus type 1 escape from RNA interference. J. Virol. 77, 11531-11535. (Pubitemid 37271651)
4. BOLCATO-BELLEMIN, A.L., BONNET, M.E., CREUSAT, G., ERBACHER, P., and BEHR, J.P. (2007). Sticky overhangs enhance siRNA-mediated gene silencing. Proc. Natl. Acad. Sci. U. S. A. 104, 16050-16055. (Pubitemid 350099361)
5. CHANG, C.I., HONG, S.W., KIM, S., and LEE, D.K. (2007). A structure-activity relationship study of siRNAs with structural variations. Biochem. Biophys. Res. Commun. 359, 997-1003. (Pubitemid 46946917)
6. CHANG, C.I., KANG, H.S., BAN, C., KIM, S., and LEE, D.K. (2009a). Dual-target gene silencing by using long, synthetic siRNA duplexes without triggering antiviral responses. Mol. Cells 27, 689-695.
7. CHANG, C.I., KIM, H.A., DUA, P., KIM, S., LI, C.J., and LEE, D.K. (2011) Structural Diversity Repertoire of Gene Silencing Small Interfering RNAs. Nucl. Acid Ther. 21, 125-131.
8. CHANG, C.I., YOO, J.W., HONG, S.W., LEE, S.E., KANG, H.S., SUN, X., ROGOFF, H.A., BAN, C., KIM, S., LI, C.J., and LEE, D.K. (2009b). Asymmetric shorter-duplex siRNA structures trigger efficient gene silencing with reduced nonspecific effects. Mol. Ther. 17, 725-732.
9. DAS, A.T., BRUMMELKAMP, T.R., WESTERHOUT, E.M., VINK, M., MADIREDJO, M., BERNARDS, R., and BERKHOUT, B. (2004). Human immunodeficiency virus type 1 escapes from RNA interference-mediated inhibition. J. Virol. 78, 2601-2605. (Pubitemid 38228957)
10. ELBASHIR, S.M., HARBORTH, J., LENDECKEL, W., YALCIN, A., WEBER, K., and TUSCHL, T. (2001a). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494-498. (Pubitemid 32494397)
11. ELBASHIR, S.M., LENDECKEL, W., and TUSCHL, T. (2001b). RNA interference is mediated by 21-and 22-nucleotide RNAs. Genes Dev. 15, 188-200. (Pubitemid 32107664)
12. ELBASHIR, S.M., MARTINEZ, J., PATKANIOWSKA, A., LENDECKEL, W., and TUSCHL, T. (2001c). Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20, 6877-6888. (Pubitemid 33134217)
13. GRIMM, D., and KAY, M.A. (2007). Combinatorial RNAi: a winning strategy for the race against evolving targets? Mol. Ther. 15, 878-888. (Pubitemid 46621646)
14. HANNON, G.J. (2002). RNA interference. Nature 418, 244-251. (Pubitemid 34773784)
15. HARADA, A., TOGAWA, H., and KATAOKA, K. (2001). Physicochemical properties and nuclease resistance of antisense-oligodeoxynucleotides entrapped in the core of polyion complex micelles composed of poly(ethylene glycol)-poly(Llysine) block copolymers. Eur. J. Pharm. Sci. 13, 35-42. (Pubitemid 32259538)
16. JUN, E.J., NAM, Y.R., AHN, J., TCHAH, H., JOO, C.H., JEE, Y., KIM, Y.K., and LEE, H. (2008). Antiviral potency of a siRNA targeting a conserved region of coxsackievirus A24. Biochem. Biophys. Res. Commun. 376, 389-394.
17. KHALED, A., GUO, S., LI, F., and GUO, P. (2005). Controllable self-assembly of nanoparticles for specific delivery of multiple therapeutic molecules to cancer cells using RNA nanotechnology. Nano. Let.t 5, 1797-1808. (Pubitemid 41396168)
18. KHVOROVA, A., REYNOLDS, A., and JAYASENA, S.D. (2003). Functional siRNAs and miRNAs exhibit strand bias. Cell 115, 209-216. (Pubitemid 37329584)
19. KIM, D.H., BEHLKE, M.A., ROSE, S.D., CHANG, M.S., CHOI, S., and ROSSI, J.J. (2005). Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23, 222-226. (Pubitemid 40255333)
20. LEE, S.Y., HUH, M.S., LEE, S., LEE, S.J., CHUNG, H., PARK, J.H., OH, Y.K., CHOI, K., KIM, K., and KWON, I.C. (2010). Stability and cellular uptake of polymerized siRNA (polysiRNA)/polyethylenimine (PEI) complexes for efficient gene silencing. J. Control. Release 141, 339-346.
21. MENENDEZ, J.A., VELLON, L., MEHMI, I., OZA, B.P., ROPERO, S., COLOMER, R., and LUPU, R. (2004). Inhibition of fatty acid synthase (FAS) suppresses HER2/neu (erbB-2) oncogene overexpression in cancer cells. Proc. Natl. Acad. Sci. U. S. A. 101, 10715-10720. (Pubitemid 38955808)
22. MOK, H., LEE, S.H., PARK, J.W., and PARK, T.G. (2010). Multimeric small interfering ribonucleic acid for highly efficient sequence-specific gene silencing. Nat. Mater. 9, 272-278.
23. SALOMON, W., BULOCK, K., LAPIERRE, J., PAVCO, P., WOOLF, T., and KAMENS, J. (2010). Modified dsRNAs that are not processed by Dicer maintain potency and are incorporated into the RISC. Nucleic Acids Res. 38, 3771-3779.
24. SASHITAL, D.G., and DOUDNA, J.A. (2010). Structural insights into RNA interference. Curr Opin. Struct. Biol. 20, 90-97.
25. SCHWARZ, D.S., HUTVAGNER, G., DU, T., XU, Z., ARONIN, N., and ZAMORE, P.D. (2003). Asymmetry in the assembly of the RNAi enzyme complex. Cell 115, 199-208. (Pubitemid 37329583)
26. URBAN-KLEIN, B., WERTH, S., ABUHARBEID, S., CZUBAYKO, F., and AIGNER, A. (2005). RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12, 461-466. (Pubitemid 40394299)
27. WANG, Y., JURANEK, S., LI, H., SHENG, G., WARDLE, G.S., TUSCHL, T., and PATEL, D.J. (2009). Nucleation, propagation and cleavage of target RNAs in Ago silencing complexes. Nature 461, 754-761.
28. WESTERHOUT, E.M., OOMS, M., VINK, M., DAS, A.T., and BERKHOUT, B. (2005). HIV-1 can escape from RNA interference by evolving an alternative structure in its RNA genome. Nucleic Acids Res. 33, 796-804. (Pubitemid 40361009)
29. WILSON, J.A., and RICHARDSON, C.D. (2006). Future promise of siRNA and other nucleic acid based therapeutics for the treatment of chronic HCV. Infect. Disord. Drug Targets 6, 43-56. (Pubitemid 43796635)
30. ZAMORE, P.D., TUSCHL, T., SHARP, P.A., and BARTEL, D.P. (2000). RNAi: double-stranded RNA directs the ATP-dependent cleavage of mRNA at 21 to 23 nucleotide intervals. Cell 101, 25-33.